Skip to main content


Hard Decisions in #RA: MTX Dosing and Monitoring Issues
1 day 4 hours ago
Mark your calendars! RheumNow Live will now be taking place on January 27 & 28! You can join us on site in Dallas, TX or virtually.
1 day 6 hours ago
Advice on Multi-Drug Failures in RA What’s your next best approach to the rheumatoid arthritis (RA) patient who has failed several DMARDs and biologics?
1 day 7 hours ago
RA QD Clinic: RA with Eye Problems Features Dr. Michael Putman (Milwaukee, WI) RA patient presents with new, chronic eye redness - what are the possibilities? RA QD Clinics are video vignettes with lessons from the clinic.
2 days 7 hours ago
Cognitive-behavioral Therapy Lessens Fibromyalgia Pain In a recent clinical trial of patients with fibromyalgia, CBT, was superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia daily.
2 days 8 hours ago
Multicentre retrospective study of 92 pts with paraneoplastic arthritis (PA), found PA seen more w/ hematological malignancies (lymphomas 26%) and solid malignancy (most were lung CA 41.5%). PA pts more likely to be CCP+ (P=0.014).
2 days 10 hours ago
What Changed FDA's Mind About Ilaris for Gout? The FDA quietly approved the interleukin (IL)-1 inhibitor canakinumab (Ilaris) for gout 10 days ago, with no announcement from either the agency or the drug's manufacturer, Novartis.
3 days 2 hours ago
Update on Anti-Drug Antibodies and Therapeutic Drug Monitoring #RA
3 days 3 hours ago
Korean retrospective cohort study betw 4/20-11/22 shows COVID infx assoc w/ increased risk of autoimmune disease; BUT 2 doses of COVID-19 vaccine was assoc w/ decrease risk of pemphigoid, Graves, APL syndrome, ITP, SLE, autoimmune arthritis
3 days 4 hours ago
Large cohort study of hospitalized #AS shows that the leading cause of death in AS were cardiovascular, infectious, respiratory, & traumatic. Mortality risk was signif assoc w/ Elixhauser comorbidity index, CHF, & renal dz. NSAIDs did not increase risk
3 days 5 hours ago
Great full-read review of advances in osteoarthritis #OA in the last 5 years (2018-2023) by Dr. Berenbaum (Ann Rheum Dis) - addressing Epidemiology, Biomarkers and Treatments
3 days 7 hours ago
Systematic review of #RA RCTs shows that the number needed to treat (NNT) for 2nd-generation biologics success is 4-6 to achieve one ACR50 response, while withdrawals due to adverse events were few and non-significant
3 days 10 hours ago